BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18176865)

  • 21. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
    Dale RC; Candler PM; Church AJ; Wait R; Pocock JM; Giovannoni G
    J Neuroimmunol; 2006 Mar; 172(1-2):187-97. PubMed ID: 16356555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.
    Sillevis Smitt P; Kinoshita A; De Leeuw B; Moll W; Coesmans M; Jaarsma D; Henzen-Logmans S; Vecht C; De Zeeuw C; Sekiyama N; Nakanishi S; Shigemoto R
    N Engl J Med; 2000 Jan; 342(1):21-7. PubMed ID: 10620645
    [No Abstract]   [Full Text] [Related]  

  • 23. Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?
    Fletcher CF; Lennon VA
    Ann Neurol; 2003 Jan; 53(1):5-7. PubMed ID: 12509841
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoimmune disorders of neuronal potassium channels.
    Newsom-Davis J; Buckley C; Clover L; Hart I; Maddison P; Tüzüm E; Vincent A
    Ann N Y Acad Sci; 2003 Sep; 998():202-10. PubMed ID: 14592877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The B cell immunobiology that underlies CNS autoantibody-mediated diseases.
    Sun B; Ramberger M; O'Connor KC; Bashford-Rogers RJM; Irani SR
    Nat Rev Neurol; 2020 Sep; 16(9):481-492. PubMed ID: 32724223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antireceptor and antichannel autoantibodies].
    Fabien N; Monier JC
    Pathol Biol (Paris); 2006 Jul; 54(6):362-9. PubMed ID: 16540262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens?
    Dalakas MC; Quarles RH
    Ann Neurol; 1996 Apr; 39(4):419-22. PubMed ID: 8619518
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders.
    Lehmann HC; Hartung HP; Hetzel GR; Stüve O; Kieseier BC
    Arch Neurol; 2006 Jul; 63(7):930-5. PubMed ID: 16831960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redox-reactive autoantibodies: detection and physiological relevance.
    McIntyre JA; Wagenknecht DR; Faulk WP
    Autoimmun Rev; 2006 Jan; 5(1):76-83. PubMed ID: 16338215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic syndromes affecting the nervous system.
    Darnell RB; Posner JB
    Semin Oncol; 2006 Jun; 33(3):270-98. PubMed ID: 16769417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new cause of limbic encephalopathy.
    Darnell RB; Posner JB
    Brain; 2005 Aug; 128(Pt 8):1745-6. PubMed ID: 16030181
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.
    Varley J; Vincent A; Irani SR
    J Neurol; 2015; 262(4):1081-95. PubMed ID: 25491076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antineuron antibodies and paraneoplastic neurological syndromes].
    Benyahia B; Carpentier AF; Delattre JY
    Rev Neurol (Paris); 2003 Apr; 159(4):463-5. PubMed ID: 12773880
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody.
    Shiihara T; Kato M; Konno A; Takahashi Y; Hayasaka K
    Brain Dev; 2007 May; 29(4):254-6. PubMed ID: 17049194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ion channels and neurological disorders].
    Imoto K; Sasaki S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Aug; 25(4):189-96. PubMed ID: 16190368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The humoral response in the pathogenesis of gluten ataxia.
    Wiendl H; Mehling M; Dichgans J; Melms A; Bürk K
    Neurology; 2003 Apr; 60(8):1397; author reply 1397-9. PubMed ID: 12707460
    [No Abstract]   [Full Text] [Related]  

  • 37. Post-streptococcal autoimmune disorders of the central nervous system.
    Dale RC
    Dev Med Child Neurol; 2005 Nov; 47(11):785-91. PubMed ID: 16225745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurologic autoantibodies: cautious enthusiasm.
    Vernino S
    Neurology; 2005 Dec; 65(11):1688-9. PubMed ID: 16344507
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles.
    Mangioris G; Halfdanarson TR; Lennon VA; Chang BK; Dubey D; Dyck PJB; Flanagan EP; McKeon A; Mills JR; Pittock SJ; Zekeridou A
    Eur J Neurol; 2024 Jun; 31(6):e16273. PubMed ID: 38466015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune lesions of the nervous system in some forms of rheumatic disorders].
    Pizova NV; Shilkina NP; Spirin NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(2):73-8. PubMed ID: 15792147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.